| Diabetes Management and Education | Lifetime | 106 | IN 3 | 98.66 |
| Diabetes Management and Research | Lifetime | 275 | IN 3 | 98.94 |
| Diabetes Treatment and Management | Lifetime | 332 | IN 2 | 98.72 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 162 | IN 1 | 97.65 |
| Diabetes and associated disorders | Lifetime | 539 | IN 8 | 97.92 |
| Pharmacology and Obesity Treatment | Lifetime | 181 | IN 2 | 97.83 |
| Chronic Disease Management Strategies | Lifetime | 447 | IN 5 | 97.21 |
| Metabolism, Diabetes, and Cancer | Lifetime | 843 | IN 5 | 97.16 |
| Dietary Effects on Health | Lifetime | 212 | IN 2 | 95.87 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 950 | IN 16 | 97.08 |
| Thyroid Disorders and Treatments | Lifetime | 703 | IN 8 | 95.80 |
| Gestational Diabetes Research and Management | Lifetime | 977 | IN 7 | 94.96 |
| Global Public Health Policies and Epidemiology | Lifetime | 698 | IN 34 | 93.44 |
| Natural Antidiabetic Agents Studies | Lifetime | 979 | IN 190 | 93.17 |
| Bariatric Surgery and Outcomes | Lifetime | 976 | IN 9 | 93.02 |
| Skin Diseases and Diabetes | Lifetime | 375 | IN 7 | 89.91 |
| History of Medicine Studies | Lifetime | 800 | IN 5 | 70.82 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 81 | IN 3 | 97.44 |
| Diabetes Management and Education | 2021-2025 | 45 | IN 2 | 96.81 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 111 | IN 2 | 96.13 |
| Diabetes Management and Research | 2021-2025 | 240 | IN 4 | 96.80 |
| Diabetes Treatment and Management | 2021-2025 | 279 | IN 4 | 96.91 |
| Diet and metabolism studies | 2021-2025 | 571 | IN 4 | 94.78 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 105 | IN 2 | 89.97 |
| Lipoproteins and Cardiovascular Health | 2021-2025 | 429 | IN 1 | 92.04 |
| Global Public Health Policies and Epidemiology | 2021-2025 | 347 | IN 26 | 86.54 |
| Obesity and Health Practices | 2021-2025 | 252 | IN 2 | 87.52 |
| Bariatric Surgery and Outcomes | 2021-2025 | 469 | IN 7 | 88.90 |
| Pharmacology and Obesity Treatment | 2021-2025 | 171 | IN 4 | 87.02 |
| Cardiovascular Health and Risk Factors | 2021-2025 | 678 | IN 13 | 80.62 |
| Skin Diseases and Diabetes | 2021-2025 | 172 | IN 14 | 71.63 |
| Thyroid Disorders and Treatments | 2021-2025 | 937 | IN 8 | 69.17 |
| Empathy and Medical Education | 2021-2025 | 931 | IN 14 | 55.35 |
